Clinical Study
Dual-Tracer Theranostic Position Emission Tomography (PET)
Position Emission Tomography (PET) /CT scans are a way to see images inside of the body. Theranostics are a combination of using a radioactive drug to diagnose and a second radioactive drug to deliver therapy. Research is needed to develop methods that combine 2 different types of scans. These may be given to patients with neuroendocrine tumors and prostate cancer. The goal of the study is to eliminate the need to have the scans given separately and combine them into one patient health clinic visit.
For more information contact:
Regan Butterfield
Regan.Butterfield@hci.utah.edu
801-646-4193
IRB#: IRB_00158172
| PI: Jeffrey Yap
| Department: HUNTSMAN CANCER INSTITUTE
| Approval Date: 2022-10-20 06:00:00
Study Categories: All Cancer Studies, Prostate Cancer Studies
| Specialties: Radiology
Who can participate?
Gender: All
Age: Over 18 years old
Volunteers: Volunteers with special conditions
Location: In Person
Inclusion Criteria:
- Ages 18 years and older
- Presence of at least 1 measurable lesion
- Diagnosis of prostate or neuroendocrine cancer
- Willing to lie flat on your back for up to one hour for data imaging
- Willing to have two separate PET/CT exams on different days within two weeks of each other
Exclusion Criteria:
- Previously participated in any therapeutic clinical study
- Known allergic or hypersensitivity reactions to radioactive drugs used for imagining
- Too claustrophobic to have PET/CT scanning
- Pregnant or currently breast feeding
Will I be paid for my time?
Yes